Table 4.
Results of the combined model for modeling both excess and relative mortality in dialyzed patients
| λexcess(se) | Effect of the covariate onλexcessPvaluea | λrel(se) | Effect of the covariate onλrelPvaluea | Max log likelihood | Effect of the covariate on both componentsPvaluesb | |
|---|---|---|---|---|---|---|
| Whole cohort | 0.19 (0.01) | 2.17 (0.17) | −6169 | |||
| Sex | ||||||
| Male | 0.17 (0.01) | 2.11 (0.21) | 0.0095 | −3788 | <0.001 | |
| Female | 0.18 (0.01) | 0.70 | 3.15 (0.35) | −2369 | ||
| Age (years) | ||||||
| <80 | 0.18 (0.02) | 0.001 | 2.04 (0.44) | 0.22 | −2500 | <0.001 |
| ≥80 | 0.28 (0.03) | 1.43 (0.25) | −2507 | |||
| First modality of dialysis | ||||||
| Hemodialysis | 0.19 (0.01) | 0.90 | 2.07 (0.18) | 0.26 | −5347 | 0.096 |
| Peritoneal dialysis | 0.19 (0.03) | 2.61 (0.45) | −820 | |||
| Primary nephropathy | ||||||
| Hypertensive/vascular | 0.17 (0.02) | 0.002 | 1.86 (0.26) | 0.077 | −2097 | <0.001 |
| Diabetes | 0.19 (0.02) | 2.99 (0.48) | −1498 | |||
| Glomerulonephritis | 0.11 (0.03) | 2.77 (0.67) | −409 | |||
| Interstitial nephritis/pyelonephritis | 0.10 (0.03) | 3.32 (0.66) | −407 | |||
| Tumoral/myeloma/amyloid | 0.41 (0.08) | 4.60 (1.71) | −275 | |||
| Miscellaneous/unknown/missing | 0.17 (0.02) | 2.33 (0.31) | −1420 |
Notes:
a
Log-likelihood ratio test comparing the K λexcess or the K λrel;
b
Log-likelihood ratio test comparing the model with and without each covariate (eg, sex: Chi-squared = −(3788 + 2369) + 6169).